Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management

1Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Mégarbane B. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol 2012;50:458–70. doi: 10.3109/15563650.2012.702218 Schep LJ Knudsen K Slaughter RJ Vale JA Mégarbane B The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol Clin Toxicol 201250458 70 10.3109/15563650.2012.702218Open DOISearch in Google Scholar

2Carter LP, Pardi D, Gorsline J, Griffiths RR. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem® Differences in characteristics and misuse. Drug Alcohol Depend 2009;104:1–10. doi: 10.1016/J. DRUGALCDEP.2009.04.012 Carter LP Pardi D Gorsline J Griffiths RR Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem® Differences in characteristics and misuse Drug Alcohol Depend 20091041 10 10.1016/J.DRUGALCDEP.2009.04.012Open DOISearch in Google Scholar

3Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001;63:1–22. doi: 10.1016/ S0376-8716(00)00191-5 Nicholson KL Balster RL GHB: a new and novel drug of abuse Drug Alcohol Depend 2001631 22 10.1016/S0376-8716(00)00191-5Open DOISearch in Google Scholar

4Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome. Eur Rev Med Pharmacol Sci 2015;19:4654–63. PMID: 26698265 Busardò FP Kyriakou C Napoletano S Marinelli E Zaami S Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome Eur Rev Med Pharmacol Sci 2015194654 63 PMID: 26698265Search in Google Scholar

5Wood DM, Brailsford AD, Dargan PI. Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Test Anal 2011;3:417–25. doi: 10.1002/dta.292 Wood DM Brailsford AD Dargan PI Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) Drug Test Anal 20113417 25 10.1002/dta.29221548140Open DOISearch in Google Scholar

6Rambourg-Schepens MO, Buffet M, Durak C, Mathieu-Nolf M. Gamma butyrolactone poisoning and its similarities to gamma hydroxybutyric acid: two case reports. Vet Hum Toxicol 1997;39:234–5. PMID: 9251175 Rambourg-Schepens MO Buffet M Durak C Mathieu-Nolf M Gamma butyrolactone poisoning and its similarities to gamma hydroxybutyric acid: two case reports Vet Hum Toxicol 199739234 5 PMID: 9251175Search in Google Scholar

7Busardò FP, Gottardi M, Tini A, Minutillo A, Sirignano A, Marinelli E, Zaami S. Replacing GHB with GBL in recreational settings: a new trend in chemsex. Curr Drug Metab 2018;19:1080–5. doi: 10.2174/13892002196661809 25090834 Busardò FP Gottardi M Tini A Minutillo A Sirignano A Marinelli E Zaami S Replacing GHB with GBL in recreational settings: a new trend in chemsex Curr Drug Metab 2018191080 5 10.2174/138920021966618092509083430251602Open DOISearch in Google Scholar

8Hibell B, Andersson B, Bjarnason T, Ahlström S, Balakireva O, Kokkevi A, Morgan M. The ESPAD report 2003 : alcohol and other drug use among students in 35 European countries. Stockholm: Swedish Council for Information on Alcohol and Other Drugs (CAN); 2004. Hibell B Andersson B Bjarnason T Ahlström S Balakireva O Kokkevi A Morgan M The ESPAD report 2003 : alcohol and other drug use among students in 35 European countries Stockholm Swedish Council for Information on Alcohol and Other Drugs (CAN) 2004Search in Google Scholar

9European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Report on the Risk Assessment of GHB in the Framework of the Joint Action on New Synthetic Drugs. Luxembourg: Office for Official Publications of the European Communities; 2002. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Report on the Risk Assessment of GHB in the Framework of the Joint Action on New Synthetic Drugs Luxembourg Office for Official Publications of the European Communities; 2002Search in Google Scholar

10Knudsen K, Greter J, Verdicchio M. High mortality rates among GHB abusers in Western Sweden. Clin Toxicol 2008;46:187–92. doi: 10.1080/15563650701263633 Knudsen K Greter J Verdicchio M High mortality rates among GHB abusers in Western Sweden Clin Toxicol 200846187 92 10.1080/1556365070126363318344100Open DOISearch in Google Scholar

11Wood DM, Nicolaou M, Dargan PI. Epidemiology of Recreational Drug Toxicity in a Nightclub Environment. Subst Use Misuse 2009;44:1495–502. doi: 10.1080/10826080802543580 Wood DM Nicolaou M Dargan PI Epidemiology of Recreational Drug Toxicity in a Nightclub Environment Subst Use Misuse 2009441495 502 10.1080/1082608080254358019938928Open DOISearch in Google Scholar

12Giorgetti R, Tagliabracci A, Schifano F, Zaami S, Marinelli E, Busardò FP. When “chems” meet sex: a rising phenomenon called “chemsex”. Curr Neuropharmacol 2017;15:762–70. doi: 10.2174/1570159X15666161117151148 Giorgetti R Tagliabracci A Schifano F Zaami S Marinelli E Busardò FP When “chems” meet sex: a rising phenomenon called “chemsex” Curr Neuropharmacol 201715762 70 10.2174/1570159X15666161117151148577105227855594Open DOISearch in Google Scholar

13Marinelli S, Berretta P, Pacifici R, Del Rio A. Sex enhancers: challenges, threats and the need for targeted measures. Clin Ter 2019;170(3):e181–3. doi: 10.7417/CT.2019.2130 Marinelli S Berretta P Pacifici R Del Rio A Sex enhancers: challenges, threats and the need for targeted measures Clin Ter 20191703e181 3 10.7417/CT.2019.213031173047Open DOISearch in Google Scholar

14Zaami S, Giorgetti R, Pichini S, Pantano F, Marinelli E, Busardò FP. Synthetic cathinones related fatalities: an update. Eur Rev Med Pharmacol Sci 2018;22:268–74. doi: 10.26355/eurrev_201801_14129 Zaami S Giorgetti R Pichini S Pantano F Marinelli E Busardò FP Synthetic cathinones related fatalities: an update Eur Rev Med Pharmacol Sci 201822268 74 10.26355/eurrev_201801_1412929364498Open DOISearch in Google Scholar

15Gentili S, Mortali C, Mastrobattista L, Berretta P, Zaami S. Determination of different recreational drugs in sweat by headspace solid-phase microextraction gas chromatography mass spectrometry (HS-SPME GC/MS): Application to drugged drivers. J Pharm Biomed Anal 2016;129:282–7. doi: 10.1016/j.jpba.2016.07.018 Gentili S Mortali C Mastrobattista L Berretta P Zaami S Determination of different recreational drugs in sweat by headspace solid-phase microextraction gas chromatography mass spectrometry (HS-SPME GC/MS): Application to drugged drivers J Pharm Biomed Anal 2016129282 7 10.1016/j.jpba.2016.07.01827442890Open DOISearch in Google Scholar

16Gamma Hydroxy Butyrate Usage, Effects and UK Prices [displayed 10 July 2019]. Available at http://www.idmu.co.uk/oldsite/ghb.htm Gamma Hydroxy Butyrate Usage, Effects and UK Prices [displayed 10 July 2019 Available at http://www.idmu.co.uk/oldsite/ghb.htmSearch in Google Scholar

17McCambridge J, Mitcheson L, Winstock A, Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 2005;100:1140–9. doi: 10.1111/j.1360-0443.2005.01127.x McCambridge J Mitcheson L Winstock A Hunt N Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom Addiction 2005;100:1140–9 10.1111/j.1360-0443.2005.01127.xOpen DOISearch in Google Scholar

18Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Use. Overview of Key Findings, 2011. Ann Arbor (MI): Institute for Social Research The University of Michigan; 2012. Johnston LD O’Malley PM Bachman JG Schulenberg JE Monitoring the Future National Results on Adolescent Drug Use. Overview of Key Findings, 2011 Ann Arbor (MI) Institute for Social Research The University of Michigan; 2012Search in Google Scholar

19Busardò FP, Bertol E, Vaiano F, Baglio G, Montana A, Barbera N, Zaami S, Romano G. Post mortem concentrations of endogenous gamma hydroxybutyric acid (GHB) and in vitro formation in stored blood and urine samples. Forensic Sci Int 2014;243:144–8. doi: 10.1016/j.forsciint.2014.07.019 Busardò FP Bertol E Vaiano F Baglio G Montana A Barbera N Zaami S Romano G Post mortem concentrations of endogenous gamma hydroxybutyric acid (GHB) and in vitro formation in stored blood and urine samples Forensic Sci Int 2014243144 8 10.1016/j.forsciint.2014.07.01925123534Open DOISearch in Google Scholar

20Marchei E, Tini A, Pirani F, Lo Faro AF, Marinelli S. Is GHB-glucuronide useful as a biomarker for the exogenous use of GHB? Eur Rev Med Pharmacol Sci 2019;23:2311–3. doi: 10.26355/eurrev_201903_17369 Marchei E Tini A Pirani F Lo Faro AF Marinelli S Is GHB-glucuronide useful as a biomarker for the exogenous use of GHB? Eur Rev Med Pharmacol Sci 2019232311 3 10.26355/eurrev_201903_1736930964152Open DOISearch in Google Scholar

21Solimini R, Rotolo MC, Pellegrini M, Minutillo A, Pacifici R, Busardò FP, Zaami S. Adulteration practices of psychoactive illicit drugs: an updated review. Curr Pharm Biotechnol 2017;18:524–30. doi: 10.2174/1389201018666 170710184531 Solimini R Rotolo MC Pellegrini M Minutillo A Pacifici R Busardò FP Zaami S Adulteration practices of psychoactive illicit drugs: an updated review Curr Pharm Biotechnol 201718524 30 10.2174/138920101866617071018453128699480Open DOISearch in Google Scholar

22Pichini S, Marchei E, Pacifici R, Marinelli E, Busardò FP. Chemsex intoxication involving sildenafil as an adulterant of GHB. Drug Test Anal 2017;9:956–9. doi: 10.1002/dta.2054 Pichini S Marchei E Pacifici R Marinelli E Busardò FP Chemsex intoxication involving sildenafil as an adulterant of GHB Drug Test Anal 20179956 9 10.1002/dta.205427527498Open DOISearch in Google Scholar

23Busardo FP, Kyriakou C. GHB in biological specimens: which cut-off levels should be taken into consideration in forensic toxicological investigation? Recent Pat Biotechnol 2014;8:206–14. doi: 10.2174/1872208309666150504143155 Busardo FP Kyriakou C GHB in biological specimens: which cut-off levels should be taken into consideration in forensic toxicological investigation? Recent Pat Biotechnol 20148206 14 10.2174/187220830966615050414315527099144Open DOISearch in Google Scholar

24Beck R, Matanović SM, Zibar L. Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat. Arh Hig Rada Toksikol 2019;70:149–50. doi: 10.2478/aiht-2019-70-3295 Beck R Matanović SM Zibar L Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat Arh Hig Rada Toksikol 201970149 50 10.2478/aiht-2019-70-329531246568Open DOISearch in Google Scholar

25Laborit H, Jouany JM, Gerard J, Fabiani F. [Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate, in French]. Presse Med 1960;68:1867–9. PMID: 13758012 Laborit H Jouany JM Gerard J Fabiani F [Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate, in French] Presse Med 1960681867 9 PMID: 13758012Search in Google Scholar

26Zaytseff A. Über die Reduction des Succinylchlorids [On the reduction of succinyl chloride, in German]. Justus Liebigs Ann Chem 1874;171:258–90. doi:10.1002/jlac.18741710216 Zaytseff A Über die Reduction des Succinylchlorids [On the reduction of succinyl chloride, in German] Justus Liebigs Ann Chem 1874171258 90 10.1002/jlac.18741710216Open DOISearch in Google Scholar

27Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of “club drugs”. Subst Use Misuse 2005;40:1189–201. doi: 10.1081/JA-200066730 Britt GC McCance-Katz EF A brief overview of the clinical pharmacology of “club drugs” Subst Use Misuse 2005401189 201 10.1081/JA-20006673016048813Open DOISearch in Google Scholar

28Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y, Ofuji T. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 1977;44:1014–7. doi: 10.1210/jcem-44-5-1014 Takahara J Yunoki S Yakushiji W Yamauchi J Yamane Y Ofuji T Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans J Clin Endocrinol Metab 1977441014 7 10.1210/jcem-44-5-1014Open DOISearch in Google Scholar

29Busardò FP, Jones AW. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes. Clin Toxicol 2019;57:149–63.doi: 10.1080/15563650.2018.1519194 Busardò FP Jones AW Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes Clin Toxicol 2019;57:149–63 10.1080/15563650.2018.1519194Open DOISearch in Google Scholar

30Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, Gallimberti L, Gessa GL, Ferrara SD. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 1993;45:353–6. doi: 10.1007/bf00265954 Palatini P Tedeschi L Frison G Padrini R Zordan R Orlando R Gallimberti L Gessa GL Ferrara SD Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers Eur J Clin Pharmacol 199345353 6 10.1007/bf00265954Open DOISearch in Google Scholar

31Cuypers E, Flanagan RJ. The interpretation of hair analysis for drugs and drug metabolites. Clin Toxicol 2018;56:90–100. doi: 10.1080/15563650.2017.1379603 Cuypers E Flanagan RJ The interpretation of hair analysis for drugs and drug metabolites Clin Toxicol 20185690 100 10.1080/15563650.2017.1379603Open DOISearch in Google Scholar

32Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 2006;370:17–49. doi: 10.1016/j.cca.2006.02.019 Pragst F Balikova MA State of the art in hair analysis for detection of drug and alcohol abuse Clin Chim Acta 200637017 49 10.1016/j.cca.2006.02.019Open DOISearch in Google Scholar

33Ferrara SD, Tedeschi L, Frison G, Orlando R, Mazzo M, Zordan R, Padrini R, Palatini P. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid. Eur J Clin Pharmacol 1996;50:305–10. doi: 10.1007/s002280050113 Ferrara SD Tedeschi L Frison G Orlando R Mazzo M Zordan R Padrini R Palatini P Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid Eur J Clin Pharmacol 199650305 10 10.1007/s002280050113Open DOISearch in Google Scholar

34Thai D, Dyer JE, Jacob P, Haller CA. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Clin Pharmacol Ther 2007;81:178–84. doi: 10.1038/sj.clpt.6100037 Thai D Dyer JE Jacob P Haller CA Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers Clin Pharmacol Ther 200781178 84 10.1038/sj.clpt.6100037Open DOISearch in Google Scholar

35Hoes MJ, Vree TB, Guelen PJ. Gamma-hydroxybutyric acid as hypnotic. Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man. Encephale 1980;6:93–9. PMID: 7449723 Hoes MJ Vree TB Guelen PJ Gamma-hydroxybutyric acid as hypnotic Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man Encephale 1980693 9 PMID: 7449723Search in Google Scholar

36Metcalf DR, Emde RN, Stripe JT. An EEG-behavioral study of sodium hydroxybutyrate in humans. Electroencephalogr Clin Neurophysiol 1966;20:506–12. doi: 10.1016/0013-4694(66)90107-6 Metcalf DR Emde RN Stripe JT An EEG-behavioral study of sodium hydroxybutyrate in humans Electroencephalogr Clin Neurophysiol 196620506 12 10.1016/0013-4694(66)90107-6Open DOISearch in Google Scholar

37van Amsterdam JGC, Brunt TM, McMaster MTB, Niesink RJM. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose. Neurosci Biobehav Rev 2012;36:1217–27. doi: 10.1016/j.neubiorev.2012.02.002 van Amsterdam JGC Brunt TM McMaster MTB Niesink RJM Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose Neurosci Biobehav Rev 2012361217 27 10.1016/j.neubiorev.2012.02.00222342779Open DOISearch in Google Scholar

38Morse BL, Morris ME. Toxicokinetics/toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: Evaluation of potential treatment strategies. J Pharmacol Exp Ther 2013;346:504–13. doi: 10.1124/jpet.113.206250 Morse BL Morris ME Toxicokinetics/toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: Evaluation of potential treatment strategies J Pharmacol Exp Ther 2013346504 13 10.1124/jpet.113.206250387677923814094Open DOISearch in Google Scholar

39Chin RL, Sporer KA, Cullison B, Dyer JE, Wu TD. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med 1998;31:716–22. doi: 10.1016/S0196-0644(98)70230-6 Chin RL Sporer KA Cullison B Dyer JE Wu TD Clinical course of gamma-hydroxybutyrate overdose Ann Emerg Med 199831716 22 10.1016/S0196-0644(98)70230-6Open DOISearch in Google Scholar

40Ortmann LA, Jaeger MW, James LP, Schexnayder SM. Coma in a 20-month-old child from an ingestion of a toy containing 1,4-butanediol, a precursor of γ-hydroxybutyrate. Pediatr Emerg Car e 2009;25:758–60. doi: 10.1097/ PEC.0b013e3181bec93b Ortmann LA Jaeger MW James LP Schexnayder SM Coma in a 20-month-old child from an ingestion of a toy containing 1,4-butanediol, a precursor of γ-hydroxybutyrate Pediatr Emerg Car e 200925758 60 10.1097/PEC.0b013e3181bec93bOpen DOISearch in Google Scholar

41Ingels M, Rangan C, Bellezzo J, Clark RF. Coma and respiratory depression following the ingestion of GHB and its precursors: three cases. J Emerg Med 2000;19:47–50. doi: 10.1016/s0736-4679(00)00188-8 Ingels M Rangan C Bellezzo J Clark RF Coma and respiratory depression following the ingestion of GHB and its precursors: three cases J Emerg Med 20001947 50 10.1016/s0736-4679(00)00188-8Open DOISearch in Google Scholar

42Williams H, Taylor R, Roberts M. Gamma-hydroxybutyrate (GHB): a new drug of misuse. Ir Med J 1998;91:56–7. PMID: 9617031 Williams H Taylor R Roberts M Gamma-hydroxybutyrate (GHB): a new drug of misuse Ir Med J 19989156 7 PMID: 9617031Search in Google Scholar

43Chin MY, Kreutzer RA, Dyer JE. Acute poisoning from gamma-hydroxybutyrate in California. West J Med 1992;156:380–4. PMCID: PMC1003276 Chin MY Kreutzer RA Dyer JE Acute poisoning from gamma-hydroxybutyrate in California West J Med 1992156380 4 PMCID: PMC1003276Search in Google Scholar

44Elian AA. Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood. Forensic Sci Int 2002;128:120–2. doi: 10.1016/S0379-0738(02)00183-4 Elian AA Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood Forensic Sci Int 2002128120 2 10.1016/S0379-0738(02)00183-4Open DOISearch in Google Scholar

45LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA. Intra- and interindividuai variations in urinary concentrations of endogenous gamma-hydroxybutyrate. J Anal Toxicol 2002;26:340–6. doi: 10.1093/jat/26.6.340 LeBeau MA Christenson RH Levine B Darwin WD Huestis MA Intra- and interindividuai variations in urinary concentrations of endogenous gamma-hydroxybutyrate J Anal Toxicol 200226340 6 10.1093/jat/26.6.340Open DOISearch in Google Scholar

46Elliott SP. Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production. Forensic Sci Int 2003;133:9–16. doi: 10.1016/s0379-0738(03)00043-4 Elliott SP Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production Forensic Sci Int 20031339 16 10.1016/s0379-0738(03)00043-4Open DOISearch in Google Scholar

47Yeatman DT, Reid K. A study of urinary endogenous gamma-hydroxybutyrate (GHB) levels. J Anal Toxicol 2003;27:40–2. doi: 10.1093/jat/27.1.40 Yeatman DT Reid K A study of urinary endogenous gamma-hydroxybutyrate (GHB) levels J Anal Toxicol 20032740 2 10.1093/jat/27.1.4012587682Open DOISearch in Google Scholar

48Sørensen LK, Hasselstrøm JB. A hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry method for the simultaneous determination of γ-hydroxybutyrate and its precursors in forensic whole blood. Forensic Sci Int 2012;222:352–9. doi: 10.1016/j.forsciint.2012.07.017 Sørensen LK Hasselstrøm JB A hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry method for the simultaneous determination of γ-hydroxybutyrate and its precursors in forensic whole blood Forensic Sci Int 2012222352 9 10.1016/j.forsciint.2012.07.01722917943Open DOISearch in Google Scholar

49Elian AA, Hackett J. Anion exchange SPE and liquid chromatography-tandem mass spectrometry in GHB analysis. J Chromatogr B 2011;879:3752–8. doi: 10.1016/j. jchromb.2011.09.018 Elian AA Hackett J Anion exchange SPE and liquid chromatography-tandem mass spectrometry in GHB analysis J Chromatogr B 20118793752 8 10.1016/j.jchromb.2011.09.01822055831Open DOISearch in Google Scholar

50Dahl SR, Olsen KM, Strand DH. Determination of γ-hydroxybutyrate (GHB), β-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and γ-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS. J Chromatogr B 2012;885–886:37–42. doi: 10.1016/j.jchromb.2011.12.009 Dahl SR Olsen KM Strand DH Determination of γ-hydroxybutyrate (GHB), β-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and γ-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS J Chromatogr B 2012885–88637 42 10.1016/j.jchromb.2011.12.00922226469Open DOISearch in Google Scholar

51Feigenbaum JJ, Howard SG. Naloxone reverses the inhibitory effect of γ-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study. Neurosci Lett 1997;224:71–4. doi: 10.1016/s0304-3940(97)13470-x Feigenbaum JJ Howard SG Naloxone reverses the inhibitory effect of γ-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study Neurosci Lett 199722471 4 10.1016/s0304-3940(97)13470-xOpen DOISearch in Google Scholar

52Devoto P, Colombo G, Cappai F, Gessa GL. Naloxone antagonizes ethanol- but not α-hydroxybutyrate-induced sleep in mice. Eur J Pharmacol 1994;252:321–4. doi: 10.1016/0014-2999(94)90179-1 Devoto P Colombo G Cappai F Gessa GL Naloxone antagonizes ethanol- but not α-hydroxybutyrate-induced sleep in mice Eur J Pharmacol 1994252321 4 10.1016/0014-2999(94)90179-1Open DOISearch in Google Scholar

53Thomas G, Bonner S, Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report. BMJ 1997;314:35–6. doi: 10.1136/bmj.314.7073.35 Thomas G Bonner S Gascoigne A Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report BMJ 199731435 6 10.1136/bmj.314.7073.35Open DOISearch in Google Scholar

54Lee DC, Satz WA, Dougherty T, Greene T. An investigation of flumazenil to antagonize gamma-hydroxybutyrate intoxication in a murine model. J Med Toxicol 2006;2:68–70. doi: 10.1007/bf03161174 Lee DC Satz WA Dougherty T Greene T An investigation of flumazenil to antagonize gamma-hydroxybutyrate intoxication in a murine model J Med Toxicol 2006268 70 10.1007/bf03161174Open DOISearch in Google Scholar

55Schmidt-Mutter C, Pain L, Sandner G, Gobaille S, Maitre M. The anxiolytic effect of γ-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. Eur J Pharmacol 1998;342:21–7. doi: 10.1016/s0014-2999(97)01503-3 Schmidt-Mutter C Pain L Sandner G Gobaille S Maitre M The anxiolytic effect of γ-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil Eur J Pharmacol 199834221 7 10.1016/s0014-2999(97)01503-3Open DOISearch in Google Scholar

56Mahr G, Bishop CL, Orringer DJ. Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse. Psychosomatics 2001;42:439–40. doi: 10.1176/appi.psy.42.5.439 Mahr G Bishop CL Orringer DJ Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse Psychosomatics 200142439 40 10.1176/appi.psy.42.5.439Open DOISearch in Google Scholar

57van Noorden MS, van Dongen LCAM, Zitman FG, Vergouwen TA. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known. Gen Hosp Psychiatry 2009;31:394–6.doi:10.1016/j.genhosppsych.2008.11.001 van Noorden MS van Dongen LCAM Zitman FG Vergouwen TA Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known Gen Hosp Psychiatry 2009;31:394–6 10.1016/j.genhosppsych.2008.11.001Open DOISearch in Google Scholar

58Miglani JS, Kim KY, Chahil R. Gamma-hydroxy butyrate withdrawal delirium: a case report. Gen Hosp Psychiatry 2000;22:213–5. doi: 10.1016/s0163-8343(00)00071-2 Miglani JS Kim KY Chahil R Gamma-hydroxy butyrate withdrawal delirium: a case report Gen Hosp Psychiatry 200022213 5 10.1016/s0163-8343(00)00071-2Open DOISearch in Google Scholar

59Hutto B, Fairchild A, Bright R. γ-Hydroxybutyrate withdrawal and chloral hydrate. Am J Psychiatry 2000;157:1706. doi: 10.1176/appi.ajp.157.10.1706 Hutto B Fairchild A Bright R γ-Hydroxybutyrate withdrawal and chloral hydrate Am J Psychiatry 20001571706 10.1176/appi.ajp.157.10.1706Open DOISearch in Google Scholar

60Craig K, Gomez HF, McManus JL, Bania TC. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J Emerg Med 2000;18:65–70. doi: 10.1016/s0736-4679(99)00163-8 Craig K Gomez HF McManus JL Bania TC Severe gamma-hydroxybutyrate withdrawal: a case report and literature review J Emerg Med 20001865 70 10.1016/s0736-4679(99)00163-8Open DOISearch in Google Scholar

61Gonzalez A, Nutt DJ. Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 2005;19:195–204. doi: 10.1177/0269881105049041 Gonzalez A Nutt DJ Gamma hydroxy butyrate abuse and dependency J Psychopharmacol 200519195 204 10.1177/026988110504904115871147Open DOISearch in Google Scholar

62Hernandez M, McDaniel CH, Costanza CD, Hernandez OJ. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid. Am J Drug Alcohol Abuse 1998;24:179–83. doi: 10.3109/00952999809001706 Hernandez M McDaniel CH Costanza CD Hernandez OJ GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid Am J Drug Alcohol Abuse 199824179 83 10.3109/009529998090017069513637Open DOISearch in Google Scholar

63McDonough M, Kennedy N, Glasper A, Bearn J. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 2004;75:3–9. doi: 10.1016/j.drugalcdep.2004.01.012 McDonough M Kennedy N Glasper A Bearn J Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review Drug Alcohol Depend 2004753 9 10.1016/j.drugalcdep.2004.01.01215225884Open DOISearch in Google Scholar

64World Health Organization (WHO). γ-Butyrolactone (GBL). Who Expert Committee on Drug Dependence. WHO Technical Report Series 973. Geneva: WHO; 2012. p. 14–5. World Health Organization (WHO). γ-Butyrolactone (GBL). Who Expert Committee on Drug Dependence. WHO Technical Report Series 973 Geneva WHO 2012 p 14–5Search in Google Scholar

65Koek W, Mercer SL, Coop A. Cataleptic effects of γ-hydroxybutyrate (GHB), its precursor γ-butyrolactone (GBL), and GABA_B receptor agonists in mice: Differential antagonism by the GABA_B receptor antagonist CGP35348. Psychopharmacology (Berl) 2007;192:407–14. doi: 10.1007/s00213-007-0718-y Koek W Mercer SL Coop A Cataleptic effects of γ-hydroxybutyrate (GHB), its precursor γ-butyrolactone (GBL), and GABA_B receptor agonists in mice: Differential antagonism by the GABA_B receptor antagonist CGP35348 Psychopharmacology (Berl) 2007192407 14 10.1007/s00213-007-0718-y17277933Open DOISearch in Google Scholar

66Carai MAM, Lobina C, Maccioni P, Cabras C, Colombo G, Gessa GL. γ-Aminobutyric acid_B (GABA_B-receptor mediation of different in vivo effects of γ-butyrolactone. J Pharmacol Sci 2008;106:199–207. doi: 10.1254/jphs. FP0071487 Carai MAM Lobina C Maccioni P Cabras C Colombo G Gessa GL γ-Aminobutyric acid_B (GABA_B-receptor mediation of different in vivo effects of γ-butyrolactone J Pharmacol Sci 2008106199 207 10.1254/jphs.FP007148718270475Open DOISearch in Google Scholar

67Goodwin AK, Brown PR, Jansen EEW, Jakobs C, Gibson KM, Weerts EM. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology (Berl) 2009;204:465–76. doi: 10.1007/s00213-009-1477-8 Goodwin AK Brown PR Jansen EEW Jakobs C Gibson KM Weerts EM Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons Psychopharmacology (Berl) 2009204465 76 10.1007/s00213-009-1477-8268263519198808Open DOISearch in Google Scholar

68Busardò FP, Pichini S, Zaami S, Pacifici R, Kintz P. Hair testing of GHB: An everlasting issue in forensic toxicology. Clin Chem Lab Med 2018;56:198–208. doi: 10.1515/cclm-2017-0397 Busardò FP Pichini S Zaami S Pacifici R Kintz P Hair testing of GHB: An everlasting issue in forensic toxicology Clin Chem Lab Med 201856198 208 10.1515/cclm-2017-039728763296Open DOISearch in Google Scholar

69Busardò FP, Kyriakou C, Cipolloni L, Zaami S, Frati P. From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate. Curr Neuropharmacol. 2016;14:17-27. doi: 10.2174/1570159x13666150407225902 Busardò FP Kyriakou C Cipolloni L Zaami S Frati P From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate Curr Neuropharmacol 20161417 27 10.2174/1570159x13666150407225902478728026813119Open DOISearch in Google Scholar

70Kyriakou C, Pellegrini M, García-Algar O, Marinelli E, Zaami S. Recent trends in analytical methods to determine new psychoactive substances in hair. Curr Neuropharmacol 2016;15:663–81. doi: 10.2174/1570159x15666161111112545 Kyriakou C Pellegrini M García-Algar O Marinelli E Zaami S Recent trends in analytical methods to determine new psychoactive substances in hair Curr Neuropharmacol 201615663 81 10.2174/1570159x15666161111112545577104427834146Open DOISearch in Google Scholar

71Dornbierer DA, Kometer M, von Rotz R, Studerus E, Gertsch J, Salomé Gachet M, Vollenweider FX, Seifritza E, Bosch OG, Quednow BB. Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring. European Neuropsychopharmacology 2019;29:539–48. doi: 10.1016/j.euroneuro.2019.02.004 Dornbierer DA Kometer M von Rotz R Studerus E Gertsch J Salomé Gachet M Vollenweider FX Seifritza E Bosch OG Quednow BB Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring European Neuropsychopharmacology 201929539 48 10.1016/j.euroneuro.2019.02.00430824339Open DOISearch in Google Scholar